Good podcast? Give it some love!
EY
EY Health Sciences & Wellness podcast seriesEpisodes
EY
EY Health Sciences & Wellness podcast series
Good podcast? Give it some love!
Rate Podcast
Episodes of EY Health Sciences & Wellness podcast series
Mark All
Search Episodes...
In this episode of the EY Health Sciences and Wellness Experience Podcast, Aloha McBride and her guests explore health inequity, sustainable change and environmental impact of the health industry. Our panel of experts discuss the evolution of
In today's episode we focus on the EY report on the Pharma supply chains of the future, and discuss the impact of global events and how a new supply chain model can emerge in the pharma industry. The speakers discuss the future of pharmaceuti
In this episode, Barend van Bergen, EY Global Long-term Value Methodology Leader and Sonja Haut, Head of Impact Valuation for Novartis discuss how companies are measuring their ESG impact. Together they review the growing importance of sustai
In this episode of the EY Health Sciences and Wellness Experience podcast, Pamela Spence, EY Global Health Sciences and Wellness Leader, talks with Nancy Flores, Executive Vice President & Chief Information and Technology Officer for McKesson C
In this episode of the EY Health Sciences and Wellness Experience podcast we focus on women in health. Join Pamela Spence, EY Global Health Sciences and Wellness Leader, as she speaks with Trecilla Lobo, SVP, People, BenevolentAI, Rabia Khan, F
In this episode of the EY Health Sciences and Wellness Experience Podcast, Pamela Spence, EY Global Health Sciences and Wellness Leader, Jackie Hunter, Board Director of Benevolent AI and Ridwaan Jhetam, VP Global Medical for Haematology, BMS,
In this episode of our EY Health and Wellness Experience podcast series, Pamela Spence is joined by Jackie Hunter, Board Director of Benevolent AI and Chair of the Brainomix Board and the Stevenage Bioscience Park, EY alumni, Susan Thomas, Dire
There are 2,600 gen and cell therapy clinical trials taking place this year. In the US alone, this could translate up to 20 new therapy approvals in 2022, which presents a clear opportunity to make more life-saving therapies available to a grea
In this episode, we delve into the global challenge of addressing health inequality with Dr. Yele Aluko, EY Chief Medical Officer, and Dr. David Rhew, Microsoft Chief Medical Officer. As experienced physicians, they share their passion for find
In this episode of Pointellis, Adlai Goldberg explores the life-changing world of cancer diagnosis and the path to full remission with Asaf Adler, Operations Senior Manager with EY. Asaf Adler, EY Americas Senior Manager for Consulting, Busines
In this first episode of our EY Health Sciences and Wellness Experience podcast series, we explore the emerging and much needed age of “Health Experience” and the disruptive health innovation emerging in the aftermath of the covid 19 pandemic.
The COVID-19 pandemic provides the ‘burning platform’ for accelerating the data agenda. New data-based tools and technologies make a more personalized approach to health and wellness possible. The world has never needed this more than now. Whil
New technologies are creating new opportunities, but they are also creating unknown and unquantified risks. Organizations that understand what it takes to succeed with new cost and revenue models, new value propositions, and new relationships w
With dealmaking a cornerstone of the growth strategy, 2020 will be a robust year for life sciences M&A. To succeed, companies must continue to focus their business models, close near term growth gaps and invest in future innovation.
In the EY 2019 Pulse of the industry, we review the performance of the global medical technology industry. The industry continues to grow, but its long-term outlook is at risk from underinvestment in R&D and lack of collaboration between indust
Nothing can change if minds do not. How can we make common ground the foundation for real change? As technology increasingly takes on the role of management, more emphasis falls on the role of leaders. Neuroscience is uncovering approaches to i
Data is the driving force underpinning the Fourth Industrial Revolution and the emergence of new business models. In health care, the goal is to use data to deliver interventions more proactively and in more personalized ways, ultimately leadin
Over the past three decades, life sciences companies have used their biological and chemical know-how to create significant value for themselves, their shareholders and most importantly patients. In today’s fast-changing environment, it’s very
An EY study shows that data and digital are transforming the life sciences industry. Hear from leaders how industry players can seize the upside of this disruption, and what it means for patient-consumers.
In EY Pulse of the industry, we examine the annual performance of the medical device industry in the context of the technological advances and rising customer expectations associated with the Fourth Industrial Revolution. To thrive in this tran
In Life Sciences 4.0: securing value through data-driven platforms, we explore how health is being reimagined because of scientific and technological change and rising customer expectations. We also examine the ramifications for life sciences c
In Life Sciences 4.0: securing value through data-driven platforms, we explore how health is being reimagined because of scientific and technological change and rising customer expectations. We also examine the ramifications for life sciences c
Join Podchaser to...
- Rate podcasts and episodes
- Follow podcasts and creators
- Create podcast and episode lists
- & much more
Unlock more with Podchaser Pro
- Audience Insights
- Contact Information
- Demographics
- Charts
- Sponsor History
- and More!
- Account
- Register
- Log In
- Find Friends
- Resources
- Help Center
- Blog
- API
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More
- © 2024 Podchaser, Inc.
- Privacy Policy
- Terms of Service
- Contact Us